Alexandria, VA — The American Thyroid Association® (ATA®) has been reaccredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education (CME) for physicians, extending its accredited status through 2030.
ACCME accreditation is a voluntary, peer-reviewed process that confirms an organization’s CME activities meet national standards for relevance, scientific rigor, and independence from commercial influence. Reaccreditation allows the ATA to continue offering CME credit — including at its Annual Meeting and other educational programs — to physicians and other healthcare professionals who treat patients with thyroid disease.
“This reaccreditation reflects the ATA’s ongoing commitment to delivering high-quality, evidence-based education for clinicians treating thyroid disease. We’re proud that our programs continue to meet ACCME’s rigorous standards, and we look forward to building on that foundation through 2030.” — Pam Mechler, CAE, Executive Director, American Thyroid Association
With this reaccreditation, the ATA will continue to designate CME credit — including AMA PRA Category 1 Credit™ — for eligible activities, and to support Maintenance of Certification (MOC) reporting for participating boards.
About the American Thyroid Association® The American Thyroid Association® is the professional home for clinicians and researchers dedicated to thyroid health. Founded in 1923, the ATA advances the treatment and prevention of thyroid disease through clinical practice guidelines, professional education, and research support.
AMERICAN THYROID ASSOCIATION® , ATA® , THYROID® , CLINICAL THYROIDOLOGY® , and the distinctive circular logo are registered in the U.S. Patent and Trademark Office as trademarks of the American Thyroid Association® , Inc.